Alx Oncology Holdings Inc (NASDAQ: ALXO) open the trading on Thursday, with great promise as it jumped 2.71% to $2.65, before settling in for the price of $2.58 at the close. Taking a more long-term approach, ALXO posted a 52-week range of $2.42-$17.83.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of -8.67% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -50.98%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 20.27%. This publicly-traded company’s shares outstanding now amounts to $49.95 million, simultaneously with a float of $30.11 million. The organization now has a market capitalization sitting at $139.58 million. At the time of writing, stock’s 50-day Moving Average stood at $5.96, while the 200-day Moving Average is $11.23.
Alx Oncology Holdings Inc (ALXO) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Alx Oncology Holdings Inc’s current insider ownership accounts for 42.83%, in contrast to 63.93% institutional ownership. According to the most recent insider trade that took place on Jul 11 ’24, this organization’s PRESIDENT & CSO sold 20,000 shares at the rate of 7.90, making the entire transaction reach 158,076 in total value, affecting insider ownership by 593,447. Preceding that transaction, on Jul 05 ’24, Company’s SVP, FINANCE AND CAO sold 1,823 for 5.50, making the whole transaction’s value amount to 10,025. This particular insider is now the holder of 92,113 in total.
Alx Oncology Holdings Inc (ALXO) Earnings and Revenue Records
Alx Oncology Holdings Inc’s EPS increase for this current 12-month fiscal period is 20.27% and is forecasted to reach -2.85 in the upcoming year.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Trading Performance Indicators
Let’s observe the current performance indicators for Alx Oncology Holdings Inc (ALXO). It’s Quick Ratio in the last reported quarter now stands at 4.39. The Stock has managed to achieve an average true range (ATR) of 0.53.
In the same vein, ALXO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.64, a figure that is expected to reach -0.78 in the next quarter, and analysts are predicting that it will be -2.85 at the market close of one year from today.
Technical Analysis of Alx Oncology Holdings Inc (ALXO)
[Alx Oncology Holdings Inc, ALXO] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 32.05% While, its Average True Range was 0.45.
Raw Stochastic average of Alx Oncology Holdings Inc (ALXO) in the period of the previous 100 days is set at 1.49%, which indicates a major fall in contrast to 6.29% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 219.97% that was higher than 124.96% volatility it exhibited in the past 100-days period.
